Journal
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
Volume 26, Issue 3, Pages 307-319Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/13803390490510031
Keywords
-
Categories
Funding
- NIDA NIH HHS [P01DA12065] Funding Source: Medline
- NIMH NIH HHS [P30MH62512-02] Funding Source: Medline
Ask authors/readers for more resources
The current study explored the predictive validity of the Global Deficit Score (GDS) approach in summarizing neuropsychological (NP) test results, and specifically in detecting HIV-associated cognitive impairment. A comprehensive NP test battery was administered to 88 HIV+ subjects and 61 healthy HIV-controls comparable for age, education, and ethnicity. Demographically corrected test data were converted to a GDS, which simulates clinicians' ratings by quantifying the number and degree of impaired performances throughout the test battery while attaching relatively less significance to superior performances and/or those within normal limits. Our results indicated that the GDS approach effectively discriminated HIV+ and normal control groups, and accurately classified HIV+ individuals with NP impairment based on the gold standard clinical rating approach. Consistent with previous studies using different subject samples and different NP test batteries, the GDS cutpoint of greater than or equal to0.50 yielded optimal balance between sensitivity and specificity in classifying NP impairment, thus supporting the generalizability of the method. Moreover, the ability of the GDS to predict NP impairment across several cutpoints was quite strong, with positive predictive power values ranging from 0.71 to 1.00. These findings support the validity of the GDS as a clinically useful way of summarizing results on NP testing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available